# Detoxification Profile Genetic Analysis - v1
**Michael Frederick - Generated October 22, 2025**

---

## Executive Summary

Two significant homozygous variants: CYP1B1 L432V (+/+) and NAT2 R197Q (+/+), plus multiple heterozygous CYP450 variants. Enhanced Phase I metabolism with reduced Phase II acetylation capacity. Normal GSTP1 provides protective glutathione conjugation.

---

## Critical Findings

### CYP1B1 L432V Homozygous (GG +/+)

**Status**: 3-fold increased enzymatic activity vs wildtype

**Role**: Phase I enzyme for estrogen and PAH metabolism

**Effects**:
- Enhanced 4-hydroxylation of estrogens (4-OH-E1/E2) - more genotoxic
- Greater PAH activation with toxin exposure
- Increased free radical production
- More reactive metabolite production
- Enhanced melatonin metabolism (beneficial)

**Cancer Risk - Complex**:

*Protective*: Chinese population studies showed GG homozygotes with reduced breast cancer risk vs CC carriers (2.79-fold lower)

*Increased Risk*: In smokers/tobacco users, GG genotype associated with increased oral, laryngeal, lung cancer risk (due to enhanced activation of tobacco carcinogens)

**Drug Sensitivity**:
- 2-fold global resistance to alkylating chemotherapy agents
- 4.5-fold resistance to camptothecins (topoisomerase I inhibitors)
- May need adjusted dosing for certain cancer drugs

**Critical Recommendations**:
- **Never smoke** - critical priority
- Minimize grilled/charred meats (PAH source)
- Avoid secondhand smoke
- Support Phase II detoxification (see below)
- Test estrogen metabolites (2-OH vs 4-OH ratio)
- Consider DIM/I3C for 2-hydroxylation support
- Air filtration for home
- Avoid plastics/xenoestrogens

---

### NAT2 R197Q Homozygous (AA +/+)

**Status**: Slow acetylator phenotype - reduced Phase II capacity

**Role**: Detoxifies aromatic amines, hetrocyclic amines (HCAs)

**Effects**:
- Slower detoxification of tobacco carcinogens
- Greater accumulation of dietary HCAs (grilled meat)
- Slower drug metabolism (many drugs)
- Increased DNA adduct formation from carcinogens

**Cancer Risk**:
- Slow acetylators who smoke: significantly higher lung, esophageal, bladder cancer risk
- Never-smokers with slow acetylator: 2.7-3.1x increased lung cancer risk (environmental toxins)
- High meat consumption: increased colorectal cancer risk (HCAs)

**Drug Metabolism**:
- **Isoniazid** (TB): increased toxicity risk
- **Sulfamethoxazole**: higher blood concentrations
- **Hydralazine, procainamide**: increased side effects
- **Dapsone**: altered metabolism
- **Caffeine**: slower metabolism (may want to reduce intake)

**Disease Associations**:
- Inflammatory bowel disease (impaired detoxification of pro-inflammatory compounds)
- Increased acrylamide sensitivity (french fries, chips, toast)

**Critical Recommendations**:
- **Never smoke** - absolutely critical
- Avoid secondhand smoke
- Minimize grilled/charred meats
- Choose low-temperature cooking (steaming, boiling, slow-cooking)
- Limit french fries, potato chips, heavily toasted foods
- Inform healthcare providers before medications (dose adjustments likely)
- Increase cruciferous vegetables (sulforaphane benefits)
- Reduce caffeine intake
- Minimize aromatic amine exposure (dyes, plastics, pesticides)

---

### SOD2 A16V Heterozygous (AG +/-)

**Role**: Mitochondrial antioxidant enzyme (superoxide → hydrogen peroxide)

**Status**: Intermediate antioxidant protection

**Associations**: Cardiovascular disease, neurological conditions, cancer susceptibility, metabolic disorders

**With Your Profile**: Combined with CYP1B1 +/+ (increased ROS from metabolites), robust antioxidant support critical

**Recommendations**:
- Vitamin C: 1000-2000 mg daily
- Vitamin E: 400 IU daily (mixed tocopherols)
- Selenium: 200 mcg daily
- CoQ10: 100-200 mg daily
- Alpha-lipoic acid: 300-600 mg daily
- Regular moderate exercise (boosts endogenous antioxidants)

---

### Additional CYP450 Heterozygous Variants

**CYP2C19*17, CYP2D6, CYP2E1, CYP3A4** (multiple +/- variants)

**Effect**: Intermediate metabolizer status for 25-50% of prescription drugs

**Implications**:
- CYP2C19: PPIs, SSRIs, antiplatelet drugs
- CYP2D6: antidepressants, antipsychotics, beta-blockers, opioids
- CYP2E1: alcohol, acetaminophen, volatile organic compounds
- CYP3A4: statins, immunosuppressants, many antibiotics

**Recommendations**:
- Comprehensive pharmacogenetic testing
- Inform providers of variants (dose adjustments needed)
- Start new medications at lower doses
- Monitor for side effects
- Consider alternatives to acetaminophen

---

### Normal GSTP1 Status (AA -/-, CC -/-)

**Status**: PROTECTIVE - normal glutathione conjugation capacity

**Strength**: This is a significant advantage offsetting some CYP1B1/NAT2 risks

**Importance**: Critical for Phase II detoxification of your enhanced Phase I metabolites

**Recommendations**:
- Optimize glutathione pathways (see below)
- NAC: 600-1200 mg daily
- Glycine: 3-5g daily
- Glutamine: 5-10g daily
- Selenium: 200 mcg daily
- Milk thistle: 300-600 mg daily

---

## Integrated Detoxification Protocol

### Phase I Support

**Nutrients**:
- B-complex (B2, B3, B6, B12, folate)
- Magnesium: 400-600 mg daily
- Zinc: 25-30 mg daily
- Copper: 2 mg daily

**Botanicals**:
- Milk thistle: 300-600 mg daily
- Schisandra: 500-1000 mg daily
- Turmeric/curcumin: 1000-2000 mg daily (with black pepper)

### Phase II Support

**Glutathione Pathway** (your strength):
- NAC: 600-1200 mg daily
- Liposomal glutathione: 250-500 mg daily
- Vitamin C: 1000-2000 mg daily
- Selenium: 200 mcg daily

**Methylation Pathway**:
- Methylfolate, methylcobalamin, B6, betaine (per methylation profile)

**Sulfation Pathway**:
- Molybdenum: 150-300 mcg daily
- MSM: 1000-2000 mg daily
- Magnesium sulfate (Epsom baths)

**Glucuronidation Pathway**:
- Calcium-D-glucarate: 500-1000 mg daily (estrogen detox)

**Glycination**:
- Glycine: 3-5g daily

### Antioxidant Protection

**Core**:
- Vitamin C: 1000-2000 mg daily
- Vitamin E: 400 IU daily (mixed tocopherols)
- Selenium: 200 mcg daily
- CoQ10: 100-200 mg daily
- Alpha-lipoic acid: 300-600 mg daily

**Polyphenols**:
- Green tea extract: 400-800 mg daily
- Resveratrol: 250-500 mg daily
- Curcumin: 1000-2000 mg daily
- Quercetin: 500-1000 mg daily

---

## Dietary Approach

### Emphasize

**Cruciferous Vegetables** (daily):
- Broccoli, Brussels sprouts, cauliflower, cabbage, kale, bok choy
- Contains sulforaphane, I3C, DIM
- Supports Phase II, estrogen metabolism

**Allium Vegetables**:
- Garlic, onions, leeks (glutathione support)

**Colorful Produce**:
- Berries, leafy greens, carrots, sweet potatoes

**Quality Proteins**:
- Wild-caught fish, organic/grass-fed meat (never charred), eggs, legumes

**Healthy Fats**:
- Olive oil, avocados, nuts, seeds, fatty fish

### Minimize/Avoid

**High-Risk**:
- Grilled, charred, blackened meats (HCAs, PAHs)
- Well-done red meat
- Processed meats (nitrates)
- French fries, chips (acrylamide)
- Heavily toasted bread

**Estrogen Disruptors**:
- Non-organic produce (pesticides)
- Conventional dairy (hormones)
- Foods in plastic containers (BPA, phthalates)

**Toxin Sources**:
- Alcohol (burdens CYP2E1, depletes glutathione)
- Processed foods
- Large predatory fish (mercury)

---

## Lifestyle

### Environmental Avoidance

- HEPA air filtration
- Water filtration
- Natural cleaning/personal care products
- Minimize plastic
- Avoid synthetic fragrances, air fresheners
- Use protective equipment for chemical exposure
- Avoid high-traffic areas (exhaust)

### Cooking Methods

**Use**: Steaming, boiling, slow-cooking, baking <350°F, sous vide

**Avoid**: Grilling, high-heat pan-frying, charring, deep-frying, smoking

### Exercise & Detox

- 150 min moderate exercise weekly
- Infrared sauna 2-3x weekly (if tolerated)
- Adequate hydration
- Promotes circulation, lymphatic flow, sweating

---

## Testing Recommendations

**Baseline**:
- Comprehensive metabolic panel
- Liver function (AST, ALT, GGT)
- Complete blood count
- Estrogen metabolites (2-OH:4-OH ratio) - CRITICAL
- Vitamin D, B vitamins
- Selenium, zinc, magnesium
- Lipid peroxides, oxidative stress markers
- Omega-3 index

**Advanced** (if available):
- Organic acids test
- Comprehensive stool analysis
- Heavy metals testing
- Mycotoxin testing
- DUTCH test (urinary estrogen metabolites)

---

## Special Considerations

### Women

- CYP1B1 +/+ significantly affects estrogen metabolism
- Monitor for estrogen dominance
- Avoid hormonal birth control if possible
- Regular breast exams, mammography
- DIM/I3C support
- Discuss with OB/GYN if planning pregnancy

### Cancer Prevention

**Enhanced Screening** (discuss with physician):
- Breast (women): earlier and more frequent
- Lung: especially if any smoking history
- Colorectal: age 45 or earlier
- Skin: annual full-body examination

**Prevention**:
- Never smoke
- Maintain healthy weight
- Regular exercise
- Mediterranean diet
- Minimize alcohol
- Optimize vitamin D

### Drug/Supplement Cautions

**Medications Requiring Caution**:
- Isoniazid (high risk)
- Sulfamethoxazole (dose adjustments)
- Acetaminophen (use sparingly, never exceed doses)
- Many antidepressants (CYP2D6)
- Tamoxifen (CYP2D6 affects activation)

**Supplements Affecting Drugs**:
- St. John's Wort (induces CYP3A4)
- Grapefruit (inhibits CYP3A4)
- Green tea extract (metabolism effects)

Always inform providers of supplements.

---

## Key Takeaway

**Enhanced Phase I + Slow Phase II Acetylation + Normal GSTP1 = Support glutathione pathways while avoiding carcinogen exposure**

Biggest priorities:
1. Never smoke
2. Avoid charred/grilled meats
3. Support estrogen detoxification
4. Optimize glutathione
5. Minimize environmental toxins
6. Inform healthcare providers of variants for drug dosing
